New study aims to cut risky pills for seniors with arthritis

NCT ID NCT07278609

Recruiting now Knowledge-focused Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

First seen Dec 12, 2025 · Last updated May 01, 2026 · Updated 18 times

Summary

This study looks at whether a special tool for doctors and easy-to-read brochures for patients can help reduce the use of potentially harmful medications in adults aged 60 and older with rheumatic diseases like arthritis or lupus. Researchers will follow 100 participants for about 18 months, tracking medication changes, hospital visits, and quality of life. The goal is to make medication use safer without causing harm.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Montreal General Hospital, McGill University Health Centre
RECRUITING

Montreal, Quebec, H3G1A4, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

Contact

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INFLAMMATORY ARTHRITIS MUSKULOSKELETAL DISEASES RHEUMATIC DISEASES SYSTEMIC AUTOIMMUNE DISEASES SYSTEMIC AUTOIMMUNE DISEASES SYSTEMIC LUPUS ERTHEMATOSUS (SLE) SYSTEMIC LUPUS ERTHEMATOSUS (SLE) VASCULITIS